Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Reinhardt

Showing results (11-20 of 107) with videos related to

Pageof 11
Sort By:
Sub-Cellular Biochemistry|March 20, 2020
Physiological Roles of the von Willebrand Factor-Factor VIII InteractionKlytaimnistra Kiouptsi, Christoph Reinhardt
British Journal of Pharmacology|August 22, 2018
Contribution of the commensal microbiota to atherosclerosis and arterial thrombosisKlytaimnistra Kiouptsi, Christoph Reinhardt
European Journal of Immunology|December 13, 2017
The gut microbiota: An emerging risk factor for cardiovascular and cerebrovascular diseaseStefanie Ascher, Christoph Reinhardt
Hamostaseologie|October 19, 2023
Animal and Cellular Models in Thrombosis and HemostasisChristoph Reinhardt, Heiko Rühl
Cold Spring Harbor Perspectives in Medicine|July 17, 2023
Gut Microbiota and the MicrovasculatureKlytaimnistra Kiouptsi, Giulia Pontarollo, Christoph Reinhardt
Microbial Cell (Graz, Austria)|January 11, 2020
A holobiont view on thrombosis: unravelling the microbiota's influence on arterial thrombus growthGiulia Pontarollo, Klytaimnistra Kiouptsi, Christoph Reinhardt
ALTEX|February 24, 2001
[ERGATT/ECVAM Workshop on Acceptance of Validated Alternative Methods: Amden III]Horst Spielmann, Manfred Liebsch, Christoph Reinhardt
Cancers|March 20, 2019
Comment on "Endothelial Protein C Receptor (EPCR), Protease Activated Receptor-1 (PAR-1) and Their Interplay in Cancer Growth and Metastatic Dissemination" <i>Cancers</i> 2019, <i>11</i>, 51Giulia Pontarollo, Florentina Melzow, Christoph Reinhardt
Circulation Research|October 26, 2018
Microbiota-Derived TrimethylamineKlytaimnistra Kiouptsi, Wolfram Ruf, Christoph Reinhardt
Signal Transduction and Targeted Therapy|October 9, 2023
Starving out brain tumors: a reprogrammed lysine catabolism serves as a novel target for glioblastoma treatmentDésirée Gül, Oliver H Krämer, Christoph Reinhardt
Pageof 11

Showing results (11-20 of 107) with videos related to

Sort By:
Pageof 11
Sub-Cellular Biochemistry|March 20, 2020
Physiological Roles of the von Willebrand Factor-Factor VIII InteractionKlytaimnistra Kiouptsi, Christoph Reinhardt
British Journal of Pharmacology|August 22, 2018
Contribution of the commensal microbiota to atherosclerosis and arterial thrombosisKlytaimnistra Kiouptsi, Christoph Reinhardt
European Journal of Immunology|December 13, 2017
The gut microbiota: An emerging risk factor for cardiovascular and cerebrovascular diseaseStefanie Ascher, Christoph Reinhardt
Hamostaseologie|October 19, 2023
Animal and Cellular Models in Thrombosis and HemostasisChristoph Reinhardt, Heiko Rühl
Cold Spring Harbor Perspectives in Medicine|July 17, 2023
Gut Microbiota and the MicrovasculatureKlytaimnistra Kiouptsi, Giulia Pontarollo, Christoph Reinhardt
Microbial Cell (Graz, Austria)|January 11, 2020
A holobiont view on thrombosis: unravelling the microbiota's influence on arterial thrombus growthGiulia Pontarollo, Klytaimnistra Kiouptsi, Christoph Reinhardt
ALTEX|February 24, 2001
[ERGATT/ECVAM Workshop on Acceptance of Validated Alternative Methods: Amden III]Horst Spielmann, Manfred Liebsch, Christoph Reinhardt
Cancers|March 20, 2019
Comment on "Endothelial Protein C Receptor (EPCR), Protease Activated Receptor-1 (PAR-1) and Their Interplay in Cancer Growth and Metastatic Dissemination" <i>Cancers</i> 2019, <i>11</i>, 51Giulia Pontarollo, Florentina Melzow, Christoph Reinhardt
Circulation Research|October 26, 2018
Microbiota-Derived TrimethylamineKlytaimnistra Kiouptsi, Wolfram Ruf, Christoph Reinhardt
Signal Transduction and Targeted Therapy|October 9, 2023
Starving out brain tumors: a reprogrammed lysine catabolism serves as a novel target for glioblastoma treatmentDésirée Gül, Oliver H Krämer, Christoph Reinhardt
Pageof 11